Find Clinical Trials
A Phase I/II, open label, non-randomized study to evaluate safety, tolerability, pharmacokinetics and clinical activity of S64315 in patients with locally advanced or metastatic breast cancer in combination with various standard treatments including hormonal and cytotoxic agents
Servier Protocol Code:
CL1-64315-003
Sponsor:
Institut de Recherches Internationales Servier
EudraCT Number:
2019-000998-23
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Solid tumors
- S064315
Other study id numbers
Other identification numbers the study may be known by.
- CL1-64315-003